Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-16

Clinical Trial Update: Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study [NA]

View source ↗

Summary

Proteus Digital Health completed a psychiatry trial using the Event Marker ingestible sensor to trigger an event recorder in patients with bipolar disorder and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Event Marker ingestible sensor (ingestible sensor)

Snippet

Sponsor: Proteus Digital Health, Inc. | Conditions: Bipolar Disorder, Schizophrenia | NA | Status: COMPLETED | Results posted: 2017-06-16